{"name":"Race Oncology Ltd","slug":"race-oncology-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Decitabine and cedazuridine","genericName":"Decitabine and cedazuridine","slug":"decitabine-and-cedazuridine","indication":"Myelodysplastic syndromes (MDS)","status":"marketed"}]}],"pipeline":[{"name":"Decitabine and cedazuridine","genericName":"Decitabine and cedazuridine","slug":"decitabine-and-cedazuridine","phase":"marketed","mechanism":"Decitabine inhibits DNA methyltransferase to reactivate silenced tumor suppressor genes, while cedazuridine protects decitabine from deamination, allowing oral administration.","indications":["Myelodysplastic syndromes (MDS)","Acute myeloid leukemia (AML)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPZVZVSF8tbDZ3ZmZKMjdLTnBrNnduZ0Ywc0FHSEw0UWJMOGhYVmFBaTRZeWMyX05Ub0xuaXl1N09PM180TnlJTm1ncFFyNk5LTGFzQ3RhUHN0bGRXM1lqVUJnU0hJUm1WakNUUTNVazVaRlh5YmZRcHZwWnBIQXBReUlvN1FyZzhCZUxFbk1lRkdmUEw3U3ZRdWs1cmZfOUNtVXA2Q2xfaE1PQVozQ1phRHhLM1E5ZHZLLWkwVkZBTUtUSkl0dHc?oc=5","date":"2025-12-23","type":"pipeline","source":"news.financial","summary":"USD 600 billion market potential – Pfizer and Bayer are in the race, Vidac Pharma in the fast lane? - news.financial","headline":"USD 600 billion market potential – Pfizer and Bayer are in the race, Vidac Pharma in the fast lane?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE00X2xnX1p4aU5DWE1Ycy1LQ21JQlJoVnA4VHluYWRFUmhnX1h2MDdpeFBTRTFOeEdoRGNncnRxTkVrdW44UURNT2d0YXQyWEFHbFFfbVRMQnZzRWNqSDdzWVE4cDQ1anNuUXNRcjZ1WUFFeXc?oc=5","date":"2025-12-10","type":"pipeline","source":"Proactive financial news","summary":"Racura Oncology Ltd Share Price - RAC, RNS News, Articles, Quotes, & Charts (ASX:RAC) - Proactive financial news","headline":"Racura Oncology Ltd Share Price - RAC, RNS News, Articles, Quotes, & Charts (ASX:RAC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxON1dudkhCY0VWajFxVzZGSlRPeWxEVXdJdTR3X1NETHo0aG5LcVVlX0FUNUxhaUp1bzU1NlNsUGc1YlRDOHNYanpRM0N5dTB1S2JqeWFqVTRUT195S3ZEWFc4VHVRNFgyc095WjFuWGFrTGxWWHRfZDVLRkp2cS1mRWFMTFh5VEQ1ZVp3RzFoclBrLU9PcElOc2FtcFltM0JOdkx1N3I0VEN6bzgwNlBlbXhhemh0elRyUk9mc29nbDdfY055MFRDUkVMNHk?oc=5","date":"2025-11-17","type":"pipeline","source":"TMX Newsfile","summary":"The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - TMX Newsfile","headline":"The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOWlFuTjVTZFdVN3I0VmdKT2tZbUk5b0JiaVhtZkRzekwtOHphbWt2U0g5TzNENU9rUUswdVlVSzkwRmxWakpmLWpZdUN6N3FZSjNyaUdzNy1CdnFIUjRSdVlBN0RCNklZbm1fUTE4dXJvVUxTUTRjaW95c3F3MUZacUc0TUU2aU1uZUxqLWpJLWtLcWpwcU9PZkprSVowNU5kY0hUWEI5MVQ3cXNsaWFVYlliVnctSFgzUE81YjJibEo1X0dycjZjVXFnSk4yekNEaHpBNkpHelNWR1ZxV2psT3VfU21YMUpMWVE?oc=5","date":"2025-11-17","type":"pipeline","source":"proactiveinvestors.com","summary":"Small cap wrap: Algernon Health, Trust Stamp, Medicus Pharma, HIVE Digital Technologies… - proactiveinvestors.com","headline":"Small cap wrap: Algernon Health, Trust Stamp, Medicus Pharma, HIVE Digital Technologies…","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1JOVI0czNZV2FWS1BuZG1OLVMtam9KM2x1WjZhME9UQmJRRjBucktyRE1nbFZXN1gzUHJEYUtPbUdhX2ZYVkZ5X2V5WEhUZVFa?oc=5","date":"2025-10-30","type":"pipeline","source":"smallcaps.com.au","summary":"Insights: Racura Oncology Ltd (ASX:RAC) - smallcaps.com.au","headline":"Insights: Racura Oncology Ltd (ASX:RAC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNLWFESF9QX2RVVHJodVlQOWg2OU5JQ1oyYVZaRWh6SEZYNTh2VUxQM0lsdFUxNmx1MGRoOG5NaEt6Q1hqaEhpWHRRLV9acmJlcGdoaHN1ajdrNFZtU09fNHNPandwTGZiUUE5NTBiVHFhQkdJbnBUWHRJcldYekt6TVJhT0JGNWV5WFdXMmpvc3VuajNVTWd6NjZ2SGEwZ0dEMVhEXzRlNjZtQXhHdm5FOVFfUFUyWVZ4MUFUNFhXc0dGSjZQRUE?oc=5","date":"2025-10-20","type":"pipeline","source":"bloomberg.com","summary":"Astra, Gilead Vie for Edge in Race to Treat Tough Triple-Negative Breast Cancer - bloomberg.com","headline":"Astra, Gilead Vie for Edge in Race to Treat Tough Triple-Negative Breast Cancer","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-03","type":"pipeline","source":"The Australian","summary":"Race achieves anticancer compound discovery - The Australian","headline":"Race achieves anticancer compound discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQN3E1ZjNQaHhaUlgwMzJxMU5aU3J0czVNRW95eXpvMFZEajROdHRPU3lNUjdBRVZJdHktaVpvbDZQVHlwQ3J5LVZUV2JEZzlhbGJpdl9vV0FWMVZnbnJNb0Y1RWhqdmJkaXl5MEdPOHllazl0Q3Z6SVVmNy1nN3FIUGczNzVpdEdwaXpBdTg5M2l1aUFkVm56UEZTMFpzR2FBdDBsWC1sMlJHcGdyajFraFduMW1kc2cxOVZzQmlHQQ?oc=5","date":"2025-10-03","type":"pipeline","source":"Stockhead","summary":"Scott Power: ASX health stocks rise; Race Oncology enjoys big week with lead drug discovery - Stockhead","headline":"Scott Power: ASX health stocks rise; Race Oncology enjoys big week with lead drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPcmhuLTdTNHo0amdCbVhJWFllUy1xaExheFR2S3JRUWl5blhXVGVhZnBMQllwUXJTRHdmTk5mM2Y2cVJNaHlzOXVFWkdmdE1CbkFfb2NLcXo0ZWZ1SEJweFdKazlqY1cxb05zVUdrVU5DTVg1LUdqbC1UNkxQb21OMVBXU2JCaWtWMDlQa054c0lPdGtmN09XWnhaMTJnRFRCdm9seTdndmN4dmVyaXhmU0ZtS042Q2tMdTRn?oc=5","date":"2025-10-02","type":"pipeline","source":"The Motley Fool Australia","summary":"Cancer drug developer’s shares race to three-year high, up 20% on new research results - The Motley Fool Australia","headline":"Cancer drug developer’s shares race to three-year high, up 20% on new research results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQVEh1SFVRUnMxQXhVTjJIdW9HWDdnZnpYOHVfQ1B6bXA2V3NlT1ktaDBuWHBUT2hSRzZKaHdjb1A2T3k0T0FlTjFtdU9yeHdJWXh2aERJYkI2TG95bU5RT0ZPa20tUHU0N0hESHFkVHl0RDNITFBBbzlhSzQ2VF8xZHBSay1DZjFDcGFfMmFsamcwQlc4RVN0M21QNmM5UnZ5UXhFQnB3c04wZW9DbW9xQnN0MlBzT181Zm1WV2JvRHVDUzlfZWtQZUdraklmNHZRT1VrdWY3Q1hzSXY1ZDM3cGUzSV9YSmpoUWFGamo2MUdfMUpTZ3BxSGVEbzRjNmV0Z1hHMHpOVGhMUnpqYmM00gGUAkFVX3lxTE5qOWlxelJnR0xOVjcxOHl4czJITU5ScHdSYWdtM2pBY29HUE5zYWZnZFJ1VmFWTDJXZXVTRmZIN0J6ZEVFZDVsaWNTa2d6RlJqZ2llUVF2OHpqVVhab01nTmZVckM5amdObk85aE5SSmdLTVl0clYweXNzSHB0Y2xUSlBxVmVIOFVqS3FGWUczd1VWYmxsQk5wU29ZTFFIMjE5eW1DRndKWERTRHVfeDdGaFVPY0ktSlZrQ1lrdkRPN3NmUmV3UnJudDN1OGVNZnU5U3hqMHYxVlZNWWJBLXBnVDVXN1NvWkFxOGlwU3FTN2ZHUGhRUm5KZDVoZTNZeTQyS0YxRWVuT1lpWFk0M2F2dHhKaA?oc=5","date":"2025-09-17","type":"pipeline","source":"The Australian","summary":"Long Shortz: Race Oncology - The Australian","headline":"Long Shortz: Race Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNZTEtTWIxejhCQXBGdXNRNjJFVjdGa1J4eEh3cTZRYVZneVROWk02dVJkS1VpYUZMSktHN2xwNVc1UlFfNTlJcTdtVS1OMEhYbW9HWVBSUlFiaGUtcC1JVTJ6YnNPQm1hd09ScGVtQzVySGJiejh0ZHJfc2RvLWxWUFVUSU9UbjVKdUowcjlJMk1qMjRhX3hzVTgtcHd0MmttQkZwVk9oSW9BZm1mcWlSWXBLWGpFcDhkNWlFSVlDZmVKTmVEQzBicnd3aTNvVWZQVU8yTVYzZ0VlYXB2dDFLRWNKa2xVdHFSMENV?oc=5","date":"2025-09-16","type":"pipeline","source":"Proactive financial news","summary":"Race Oncology moves to secure IP protection for ‘breakthrough' bisantrene discovery - Proactive financial news","headline":"Race Oncology moves to secure IP protection for ‘breakthrough' bisantrene discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPX0h1cUdHcFoyUXRVOWxvTGFZM21Rbmt6OXdaN21MY3BySnk2dVEwMGVNcHVzRHNySFkxUk1NVllDeE9qMmlvLTh5VnJ0NE5JSmJ2c0hOZ04xUXowSWFEXzZzWmZQOUNXT1kwN1otbGx0OHhyUDBTZklNaDg0b2hJTFd3TGVlRXNSNHBDVTU3WlI3Q1V4R0MxQTRtQ0RXdnlhWTdTZ3Njb3pxTzhUZFNNQ0ROYndkNVFvdEJLSlc1cmpHRlFvajRUZVA3dC1aaFN1TTlqNlFnQS1KLTR3c1Rac0FBX3A4NDd5dUE?oc=5","date":"2025-06-18","type":"trial","source":"Proactive Investors","summary":"Race Oncology doses first patient in trial of RC220 + doxorubicin for solid tumours - Proactive Investors","headline":"Race Oncology doses first patient in trial of RC220 + doxorubicin for solid tumours","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}